Sector
PharmaceuticalsOpen
₹27.94Prev. Close
₹26.61Turnover(Lac.)
₹0.28Day's High
₹27.94Day's Low
₹27.9452 Week's High
₹26.6152 Week's Low
₹18.04Book Value
₹15.62Face Value
₹10Mkt Cap (₹ Cr.)
69.71P/E
349.25EPS
0.08Divi. Yield
016 Sep 2024
12:00 AM
BookCloser
12 Apr 2025
12:00 AM
EGM
9 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
2 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 8.1 | 8.1 | 8.1 | 8.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -0.75 | -0.9 | -0.86 | 0.7 |
Net Worth | 7.35 | 7.2 | 7.24 | 8.8 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Revenue | 3.5 | 0.92 | 1.45 | 5.74 |
yoy growth (%) | 277.33 | -36.13 | -74.63 | -3.58 |
Raw materials | -2.84 | 0 | -0.32 | -4.24 |
As % of sales | 81.2 | 0 | 22.17 | 73.84 |
Employee costs | -0.21 | -0.23 | -0.06 | -0.33 |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Profit before tax | 0.2 | 0.13 | 0.08 | 0.6 |
Depreciation | -0.12 | -0.33 | -0.39 | -0.28 |
Tax paid | -0.05 | -0.03 | -0.06 | -0.19 |
Working capital | 1.37 | -1.5 | -0.84 | 0.27 |
Other operating items |
| Y/e 31 Mar | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 277.33 | -36.13 | -74.63 | -3.58 |
Op profit growth | -53.77 | -18.59 | -45.17 | 8.52 |
EBIT growth | 50.64 | 47.78 | -85.1 | 11.11 |
Net profit growth | 53.57 | 427.68 | -95.52 | 10.19 |
| Particulars (Rupees in Crores.) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|---|
Gross Sales | 8.61 | 9.24 | 10.24 | 10.46 | 10.5 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8.61 | 9.24 | 10.24 | 10.46 | 10.5 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.64 | 0.34 | 0.6 | 0.38 | 0.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,686.25 | 128.43 | 4,04,587.86 | 1,181.05 | 0.8 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,940.85 | 76.08 | 1,57,710.9 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,512 | 26.24 | 1,22,115.23 | 1,438.15 | 0.86 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,238 | 60.07 | 1,09,583.71 | 485 | 0.86 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,497.8 | 53.29 | 1,03,053.87 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Monam Kapoor
Independent Director
Janardhan Das Kabra
Whole-time Director
Venkateshwarlu Pulluru
Company Sec. & Compli. Officer
Nishita Kalantri
Non Executive Director
Jivamohan Divakar Valluri
Non Executive Director
Lakshman Samala
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Trimurthi Ltd
Summary
Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company. Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016.Initially, the company was engaged in finance and investments in securities. They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company. Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.In November 2009, the Company received NS-EN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from Kvalitet Veritas Quality Assurance. They had been appointed as Authorized Distributors on all India level for Livewell Food products and ABLE, Pharma, in the Salon District of Himachal Pradesh.During the year 2010-11, the Company started their first Pharmacy Retail Outlet in Himayath Nagar, Hyderabad. Also, they started their second retail outlet at Inderbagh, Sultan Bazar, Hyderabad. The Company with its full capacity commenced the business operations in food industry business through its wholly owned subsidiary in 2018.The Co
Read More
What is the Novelix Pharmaceuticals Ltd share price today?
The Novelix Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹27.94 today.
What is the Market Cap of Novelix Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Novelix Pharmaceuticals Ltd is ₹69.71 Cr. as of 12 May ‘25
What is the PE and PB ratio of Novelix Pharmaceuticals Ltd?
The PE and PB ratios of Novelix Pharmaceuticals Ltd is 349.25 and 1.79 as of 12 May ‘25
What is the 52 Week High and Low of Novelix Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a Novelix Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Novelix Pharmaceuticals Ltd is ₹18.04 and ₹26.61 as of 12 May ‘25
What is the CAGR of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd's CAGR for 5 Years at 67.31%, 3 Years at 41.46%, 1 Year at 54.80%, 6 Month at 15.70%, 3 Month at 4.97% and 1 Month at 0.00%.
What is the shareholding pattern of Novelix Pharmaceuticals Ltd?
The shareholding pattern of Novelix Pharmaceuticals Ltd is as follows:
Promoters - 66.56 %
Institutions - 0.00 %
Public - 33.44 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
